DBVT Q2 2018 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$538M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-6.6% YoY

Gross Profit

$3M100.0% margin

Operating Income

-$43M-1258.1% margin

Net Income

-$42M-1233.3% margin

EPS (Diluted)

$-7.60

QoQ Revenue Growth

-5.2%

Cash Flow

Operating Cash Flow

-$38M

Free Cash Flow

-$38M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$336M

Total Liabilities

$61M

Stockholders' Equity

$275M

Cash & Equivalents

$271M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$4M	-6.6%
Gross Profit	$3M	$4M	-6.6%
Operating Income	-$43M	-$41M	-5.7%
Net Income	-$42M	-$41M	-1.6%